Autoantibodies targeted against β-cell antigens, specifically against insulin, glutamic acid, decarboxylase, zinc cation efflux transporter and tyrosine phosphatases-2 and -2b, have been detected since T1DM first appeared [5,6,7]. Here, INS is linked to type 1 diabetes mellitus.